美国 · SEC FORM 4
KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · Nasdaq · CIK 0001877184 · Healthcare · Medical Instruments & Supplies
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
55 同一窗口内观察到的 Form 4 交易行
37 sales · 18 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-03-26 · COHEN RAYMOND W.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,277,779
- 上期报告
- 3,123,641
- 日均成交量
- 449,973
- 回补天数
- 7.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-26 | COHEN RAYMOND W | 买入 (P) | Common Shares | 10,000 | USD 19.98 | USD 199,800 | SEC 申报 ↗ |
| 2025-03-07 | Umberger Traci S | 买入 (P) | Common Shares | 13,500 | USD 17.00 | USD 229,500 | SEC 申报 ↗ |
| 2025-03-07 | Ford Alfred J Jr | 买入 (P) | Common Shares | 20,000 | USD 17.00 | USD 340,000 | SEC 申报 ↗ |
| 2025-03-07 | COHEN RAYMOND W | 买入 (P) | Common Shares | 17,000 | USD 17.00 | USD 289,000 | SEC 申报 ↗ |
Form 4 申报证据
66 transaction lines in the latest 365-day window; 79 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | COHEN RAYMOND W | 卖出 (S) | Common Shares | 3,330 | USD 29.28 | USD 97,504 | SEC 申报 ↗ |
| 2026-09-21 | Kwo Elizabeth | 卖出 (S) | Common Shares | 4,010 | USD 24.26 | USD 97,283 | SEC 申报 ↗ |
| 2026-09-09 | Schwartz Jeffrey Lawrence | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | COHEN RAYMOND W | 卖出 (S) | Common Shares | 3,330 | USD 29.28 | USD 97,504 | SEC 申报 ↗ |
| 2026-09-21 | Kwo Elizabeth | 卖出 (S) | Common Shares | 4,010 | USD 24.26 | USD 97,283 | SEC 申报 ↗ |
| 2026-09-09 | Schwartz Jeffrey Lawrence | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-09 | Reilly Kevin C | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-09 | Ladone Mary Kay | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-09 | Kwo Elizabeth | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-09 | Hanley Conor | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-09 | COHEN RAYMOND W | 奖励／授予 (A) | Common Shares | 7,217 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-08 | Schwartz Jeffrey Lawrence | 卖出 (S) | Common Shares | 3,890 | USD 25.18 | USD 97,950 | SEC 申报 ↗ |
| 2026-09-08 | Reilly Kevin C | 卖出 (S) | Common Shares | 2,932 | USD 25.13 | USD 73,681 | SEC 申报 ↗ |
| 2026-09-08 | Ladone Mary Kay | 卖出 (S) | Common Shares | 3,908 | USD 25.20 | USD 98,482 | SEC 申报 ↗ |
| 2026-09-08 | Hanley Conor | 卖出 (S) | Common Shares | 5,694 | USD 25.25 | USD 143,774 | SEC 申报 ↗ |
| 2026-08-17 | Webster Brian Daniel | 卖出 (S) | Common Shares | 15,000 | USD 27.48 | USD 412,200 | SEC 申报 ↗ |
| 2026-08-07 | Mahboob Vaseem | 卖出 (S) | Common Shares | 26,287 | USD 25.88 | USD 680,275 | SEC 申报 ↗ |
| 2026-08-04 | Webster Brian Daniel | 卖出 (S) | Common Shares | 51,900 | USD 24.52 | USD 1,272,615 | SEC 申报 ↗ |
| 2026-08-04 | Umberger Traci S | 卖出 (S) | Common Shares | 3,580 | USD 24.04 | USD 86,063 | SEC 申报 ↗ |
| 2026-08-04 | Mahboob Vaseem | 卖出 (S) | Common Shares | 6,995 | USD 24.68 | USD 172,645 | SEC 申报 ↗ |
| 2026-08-04 | Ford Alfred J Jr | 卖出 (S) | Common Shares | 6,275 | USD 24.09 | USD 151,165 | SEC 申报 ↗ |
| 2026-08-03 | Webster Brian Daniel | 卖出 (S) | Common Shares | 13,017 | USD 23.92 | USD 311,367 | SEC 申报 ↗ |
| 2026-08-03 | Umberger Traci S | 卖出 (S) | Common Shares | 7,590 | USD 23.86 | USD 181,097 | SEC 申报 ↗ |
| 2026-08-03 | Moran Timothy P. | 卖出 (S) | Common Shares | 2,380 | USD 23.76 | USD 56,549 | SEC 申报 ↗ |
| 2026-08-03 | Mahboob Vaseem | 卖出 (S) | Common Shares | 5,391 | USD 23.80 | USD 128,306 | SEC 申报 ↗ |
| 2026-08-03 | Ford Alfred J Jr | 卖出 (S) | Common Shares | 13,015 | USD 23.90 | USD 311,058 | SEC 申报 ↗ |
| 2026-07-31 | Webster Brian Daniel | 卖出 (S) | Common Shares | 8,948 | USD 22.60 | USD 202,225 | SEC 申报 ↗ |
| 2026-07-31 | Umberger Traci S | 卖出 (S) | Common Shares | 8,752 | USD 22.60 | USD 197,795 | SEC 申报 ↗ |
| 2026-07-31 | Moran Timothy P. | 卖出 (S) | Common Shares | 8,759 | USD 22.61 | USD 198,041 | SEC 申报 ↗ |
| 2026-07-31 | Mahboob Vaseem | 卖出 (S) | Common Shares | 8,817 | USD 22.61 | USD 199,352 | SEC 申报 ↗ |
| 2026-07-31 | Ford Alfred J Jr | 卖出 (S) | Common Shares | 8,681 | USD 22.61 | USD 196,277 | SEC 申报 ↗ |
| 2026-07-30 | Webster Brian Daniel | 卖出 (S) | Common Shares | 7,857 | USD 22.72 | USD 178,511 | SEC 申报 ↗ |
| 2026-07-30 | Umberger Traci S | 卖出 (S) | Common Shares | 5,887 | USD 22.74 | USD 133,870 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | KMTS |
| CIK | 0001877184 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 79 transaction lines from 2025-03-07 to 2026-09-30 4 P purchase lines · 45 S sale lines · 30 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.